Skip to main content
OpenTrials
Completed

NCT Number: NCT01324050

Internet-delivered Psychodynamic Therapy for Depression

The overall aim of this study is to develop and test a psychodynamic Internet-delivered psychological treatment for patients with mild to moderate major depression and compare its efficacy to an active control group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression Behavior Behavioral Symptoms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Linköping University, Linköping, Sweden

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Major Depressive Disorder
  • 15 or more on MADRS-S

Exclusion criteria

  • Severe depression (more than 35 on MADRS-S or based on interview)
  • Severe psychiatric condition (e.g. psychosis or bipolar disorder)
  • Suicidal (measured in diagnostic interview)
  • Changed medication during the last three months

Treatment and study plan

Internet-delivered psychodynamic therapy for depression

Behavioral

This intervention contains 9 text-based self-help modules. These modules contain material inspired by psychoanalytic theory about identifying reoccurring patterns in life among other things. In addition to the self-help modules, 10-15 minutes of therapist contact is given every week. In total, the intervention will last for 10 weeks.

Internet-delivered therapist support

Behavioral

This intervention contains 1 text-based self-help module, which is mainly based on information on depression. In addition to this text, the participants in this group gets 10-15 minutes of therapist contact every week. In the conversation with the therapist, the participant informs the therapist about the activities during the week. This intervention is considered to be a form of support. In total, the intervention will last for 10 weeks.

Primary outcomes

  1. Beck Depression Inventory (BDI)

    Time frame: Two weeks before the treatment starts

  2. Beck Depression Inventory (BDI)

    Time frame: At treatment start (0 weeks)

  3. Beck Depression Inventory (BDI)

    Time frame: At treatment termination (10 weeks)

Secondary outcomes

  1. Beck Anxiety Inventory (BAI)

    Time frame: Two weeks before the treatment starts

  2. Beck Anxiety Inventory (BAI)

    Time frame: At treatment termination (10 weeks)

  3. Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)

    Time frame: Two weeks before treatment starts

  4. Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)

    Time frame: At treatment termination (10 weeks)

  5. Quality of Life Inventory (QOLI)

    Time frame: Two weeks before treatment starts

  6. Quality of Life Inventory (QOLI)

    Time frame: At treatment termination (10 weeks)

  7. Patient Health Questionnaire 9 (PHQ-9)

    Time frame: Two weeks before treatment starts

  8. Patient Health Questionnaire 9 (PHQ-9)

    Time frame: At treatment termination (10 weeks)

  9. Generalised Anxiety Disorder Assessment 7 (GAD-7)

    Time frame: Two weeks before treatment starts

  10. Generalised Anxiety Disorder Assessment 7 (GAD-7)

    Time frame: At treatment termination (10 weeks)

Sponsors and collaborators

Lead sponsor

Linkoeping University

Other Gov

Registry information

Official study title

Internet-delivered Psychodynamic Therapy for Depression: a Randomized Controlled Trial

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Mar 28, 2011
Registry last updated
Aug 2, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.